Robert Langenbach
- Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects 48
- Pharmacogenetics and Drug Metabolism 13
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology 13
- Cancer Research top 1%
- Carcinogens and Genotoxicity Assessment 33
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 48
- Pharmacogenetics and Drug Metabolism 13
- Genetics top 1%
- Estrogen and related hormone effects 23
-
- Asthma and respiratory diseases 9
-
- DNA Repair Mechanisms 8
-
- Chemical Reactions and Isotopes 7
- Co-authors
- Howard F. TianoScott G. MorhamCharles D. LoftinOliver SmithiesChristopher A. LeeWilliam L. SmithJoel F. MahlerPatricia C. Chulada
- Journals
- Carcinogenesis (8 papers)Journal of Clinical Investigation (7 papers)Molecular Carcinogenesis (6 papers)
- Partner nations
- United StatesIsraelChina
In The Last Decade
Robert Langenbach
122 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Pharmacology 3.5k
- Biochemistry 1.2k
- Cancer Research 1.6k
- Pharmacology 785
- Genetics 1.8k
Countries citing papers authored by Robert Langenbach
This map shows the geographic impact of Robert Langenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Langenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Langenbach more than expected).
Fields of papers citing papers by Robert Langenbach
This network shows the impact of papers produced by Robert Langenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Langenbach. The network helps show where Robert Langenbach may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Langenbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 30 | |
| 2 | 2012 | 9 | |
| 3 | 2007 | 22 | |
| 4 | 2007 | 31 | |
| 5 | 2007 | 7 | |
| 6 | 2007 | 23 | |
| 7 | 2004 | 51 | |
| 8 | 2004 | 84 | |
| 9 | 2003 | 54 | |
| 10 | 2000 | 231 | |
| 11 | 1999 | 185 | |
| 12 | 1995 | 27 | |
| 13 | Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationbreakdown → | 1995 | 943 |
| 14 | 1994 | 70 | |
| 15 | 1993 | 61 | |
| 16 | 1989 | 50 | |
| 17 | 1988 | 3 | |
| 18 | 1987 | 9 | |
| 19 | Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium. | 1983 | 30 |
| 20 | Maintenance of adult rat hepatocytes on C3H/10T1/2 cells. | 1979 | 50 |
About Robert Langenbach
Robert Langenbach is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 124 papers that have together received 8.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (48 papers), Carcinogens and Genotoxicity Assessment (33 papers), Estrogen and related hormone effects (23 papers), Eicosanoids and Hypertension Pharmacology (13 papers), Pharmacogenetics and Drug Metabolism (13 papers), Asthma and respiratory diseases (9 papers), DNA Repair Mechanisms (8 papers) and Chemical Reactions and Isotopes (7 papers). The work is most often cited by research in Pharmacology (3.5k citations), Biochemistry (1.2k citations) and Cancer Research (1.6k citations). Robert Langenbach has collaborated with scholars based in United States, Israel and China. Frequent co-authors include Howard F. Tiano, Scott G. Morham, Charles D. Loftin, Oliver Smithies, Christopher A. Lee, William L. Smith, Joel F. Mahler, Patricia C. Chulada, Eliezer Huberman and Kimberly D. Kluckman. Their work appears in journals such as Carcinogenesis, Journal of Clinical Investigation, Molecular Carcinogenesis, Cancer Letters and Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.